Vertex Pharmaceuticals | Betriebsaufwand

Aktienkurs
465.76
Täglich Wechseln
-6.25 -1.32%
Monatlich
3.78%
Jährlich
-3.43%
Q1 Prognose
455.43




Betriebsaufwand Veränderung Datum
AbbVie USD -2.64B 12.35B 2025-09
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amgen USD 5.13B 1.39B 2025-09
Arrowhead Research USD 212.37M 19.05M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 18.55B 10.06B 2025-09
Gilead Sciences USD 4.26B 95M 2025-09
Incyte USD 4.65B 3.75B 2025-09
Insmed USD 403.69M 42.4M 2025-09
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
J&J USD 18.97B 2.38B 2025-12
Merck USD 10.72B 1.28B 2025-09
Moderna USD 1.28B 232M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Novartis USD 9.86B 115M 2025-09
Pfizer USD 92.8B 82.47B 2025-09
PTC Therapeutics USD 207.52M 6.21M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
United Therapeutics USD 6.59B 6.07B 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09


Vertex Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.